» Articles » PMID: 37048159

Quadra-Stable Dynamics of P53 and PTEN in the DNA Damage Response

Overview
Journal Cells
Publisher MDPI
Date 2023 Apr 13
PMID 37048159
Authors
Affiliations
Soon will be listed here.
Abstract

Cell fate determination is a complex process that is frequently described as cells traveling on rugged pathways, beginning with DNA damage response (DDR). Tumor protein p53 (p53) and phosphatase and tensin homolog (PTEN) are two critical players in this process. Although both of these proteins are known to be key cell fate regulators, the exact mechanism by which they collaborate in the DDR remains unknown. Thus, we propose a dynamic Boolean network. Our model incorporates experimental data obtained from NSCLC cells and is the first of its kind. Our network's wild-type system shows that DDR activates the G2/M checkpoint, and this triggers a cascade of events, involving p53 and PTEN, that ultimately lead to the four potential phenotypes: cell cycle arrest, senescence, autophagy, and apoptosis (quadra-stable dynamics). The network predictions correspond with the gain-and-loss of function investigations in the additional two cell lines (HeLa and MCF-7). Our findings imply that p53 and PTEN act as molecular switches that activate or deactivate specific pathways to govern cell fate decisions. Thus, our network facilitates the direct investigation of quadruplicate cell fate decisions in DDR. Therefore, we concluded that concurrently controlling PTEN and p53 dynamics may be a viable strategy for enhancing clinical outcomes.

Citing Articles

Divergent PTEN-p53 interaction upon DNA damage in a human thyroid organoid model with germline PTEN mutations.

Venegas J, Onur O, Kang S, Hitomi M, Eng C Endocr Relat Cancer. 2025; 32(4).

PMID: 39970536 PMC: 11906015. DOI: 10.1530/ERC-24-0216.


Decoding PTEN: from biological functions to signaling pathways in tumors.

Huang X, Zhang D, Zhang D, Guo J, Gu G, Wang Y Mol Biol Rep. 2024; 51(1):1089.

PMID: 39446204 DOI: 10.1007/s11033-024-10049-y.


LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.

Gupta S, Silveira D, Lorenzoni P, Mombach J, Hashimoto R Int J Mol Sci. 2024; 25(15).

PMID: 39125832 PMC: 11311614. DOI: 10.3390/ijms25158264.


PTEN: an emerging target in rheumatoid arthritis?.

Zhou P, Meng X, Nie Z, Wang H, Wang K, Du A Cell Commun Signal. 2024; 22(1):246.

PMID: 38671436 PMC: 11046879. DOI: 10.1186/s12964-024-01618-6.


A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer.

Gupta S, Silveira D, Piedade G, Ostrowski M, Mombach J, Hashimoto R Noncoding RNA Res. 2023; 9(1):185-193.

PMID: 38125755 PMC: 10730431. DOI: 10.1016/j.ncrna.2023.10.008.


References
1.
Luserna di Rora A, Cerchione C, Martinelli G, Simonetti G . A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. J Hematol Oncol. 2020; 13(1):126. PMC: 7507691. DOI: 10.1186/s13045-020-00959-2. View

2.
Charrier-Savournin F, Chateau M, Gire V, Sedivy J, Piette J, Dulic V . p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell. 2004; 15(9):3965-76. PMC: 515331. DOI: 10.1091/mbc.e03-12-0871. View

3.
Blagosklonny M . Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY). 2012; 4(3):159-65. PMC: 3348476. DOI: 10.18632/aging.100443. View

4.
Chatr-Aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas N . The BioGRID interaction database: 2017 update. Nucleic Acids Res. 2016; 45(D1):D369-D379. PMC: 5210573. DOI: 10.1093/nar/gkw1102. View

5.
Gupta S, Hashimoto R . Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer. Biomolecules. 2022; 12(3). PMC: 8946683. DOI: 10.3390/biom12030420. View